Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association

Mostrar otras versiones (2)

Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as conventional TACE using Lipiodol in the 1980s. In the 2000s, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yuri, Choi, Jin Woo, Kwon, Hoon, Kim, Kun Yung, Lee, Byung Chan, Chu, Hee Ho, Lee, Dong Hyeon, Lee, Han Ah, Kim, Gyoung Min, Oh, Jung Suk, Hyun, Dongho, Lee, In Joon, Rhim, Hyunchul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2023
Materias:
Recommendation and Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565548/
https://www.ncbi.nlm.nih.gov/pubmed/37449302
http://dx.doi.org/10.17998/jlc.2023.05.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565548/
https://www.ncbi.nlm.nih.gov/pubmed/37449302
http://dx.doi.org/10.17998/jlc.2023.05.22

Ejemplares similares